vs
Side-by-side financial comparison of Employers Holdings, Inc. (EIG) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $170.5M, roughly 1.6× Employers Holdings, Inc.). On growth, HUTCHMED (China) Ltd posted the faster year-over-year revenue change (-16.5% vs -21.3%).
Employers Holdings, Inc. is a U.S.-headquartered insurance holding company that specializes in offering workers' compensation insurance and customized risk management services primarily for small and medium-sized enterprises across the United States. It mainly serves clients in low-to-medium hazard industries, helping them mitigate workplace safety risks and meet relevant regulatory requirements for employee protection.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
EIG vs HCM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $170.5M | $270.8M |
| Net Profit | — | $2.0M |
| Gross Margin | — | 37.7% |
| Operating Margin | — | -13.2% |
| Net Margin | — | 0.7% |
| Revenue YoY | -21.3% | -16.5% |
| Net Profit YoY | — | -83.6% |
| EPS (diluted) | — | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $170.5M | — | ||
| Q4 25 | $188.5M | $270.8M | ||
| Q3 25 | $239.3M | — | ||
| Q2 25 | $246.3M | $277.7M | ||
| Q1 25 | $202.6M | $324.5M | ||
| Q4 24 | $216.6M | — | ||
| Q3 24 | $224.0M | — | ||
| Q2 24 | $217.0M | $305.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.0M | ||
| Q3 25 | $-8.3M | — | ||
| Q2 25 | $29.7M | $455.0M | ||
| Q1 25 | $12.8M | $11.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | $30.3M | — | ||
| Q2 24 | $31.7M | $25.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 37.7% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 48.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 41.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | -13.2% | ||
| Q3 25 | -4.7% | — | ||
| Q2 25 | 15.0% | -1.3% | ||
| Q1 25 | 7.8% | -5.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | 16.4% | — | ||
| Q2 24 | 18.4% | -9.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.7% | ||
| Q3 25 | -3.5% | — | ||
| Q2 25 | 12.1% | 163.8% | ||
| Q1 25 | 6.3% | 3.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | 13.5% | — | ||
| Q2 24 | 14.6% | 8.4% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.93 | $0.00 | ||
| Q3 25 | $-0.36 | — | ||
| Q2 25 | $1.23 | $0.52 | ||
| Q1 25 | $0.52 | $0.01 | ||
| Q4 24 | $1.14 | — | ||
| Q3 24 | $1.21 | — | ||
| Q2 24 | $1.25 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $169.9M | $1.4B |
| Total DebtLower is stronger | — | $93.2M |
| Stockholders' EquityBook value | $955.7M | $1.2B |
| Total Assets | $3.4B | $1.8B |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $169.9M | — | ||
| Q4 25 | $169.9M | $1.4B | ||
| Q3 25 | $172.4M | — | ||
| Q2 25 | $78.1M | $1.4B | ||
| Q1 25 | $100.4M | $836.1M | ||
| Q4 24 | $68.4M | — | ||
| Q3 24 | $173.9M | — | ||
| Q2 24 | $126.4M | $802.5M |
| Q1 26 | — | — | ||
| Q4 25 | $19.0M | $93.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $82.1M |
| Q1 26 | $955.7M | — | ||
| Q4 25 | $955.7M | $1.2B | ||
| Q3 25 | $1.0B | — | ||
| Q2 25 | $1.1B | $1.2B | ||
| Q1 25 | $1.1B | $759.9M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.0B | $740.1M |
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.4B | $1.8B | ||
| Q3 25 | $3.5B | — | ||
| Q2 25 | $3.5B | $1.8B | ||
| Q1 25 | $3.6B | $1.3B | ||
| Q4 24 | $3.5B | — | ||
| Q3 24 | $3.6B | — | ||
| Q2 24 | $3.5B | $1.3B |
| Q1 26 | — | — | ||
| Q4 25 | 0.02× | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $8.2M |
| Free Cash FlowOCF − Capex | — | $3.4M |
| FCF MarginFCF / Revenue | — | 1.2% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | — | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $44.7M | $8.2M | ||
| Q3 25 | $29.4M | — | ||
| Q2 25 | $0 | $-72.9M | ||
| Q1 25 | $14.6M | $40.3M | ||
| Q4 24 | $76.4M | — | ||
| Q3 24 | $51.0M | — | ||
| Q2 24 | $11.7M | $-39.8M |
| Q1 26 | — | — | ||
| Q4 25 | $44.6M | $3.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-82.2M | ||
| Q1 25 | — | $32.5M | ||
| Q4 24 | $76.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-49.9M |
| Q1 26 | — | — | ||
| Q4 25 | 23.7% | 1.2% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | 10.0% | ||
| Q4 24 | 35.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -16.3% |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 1.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.21× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.00× | -0.16× | ||
| Q1 25 | 1.14× | 3.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.68× | — | ||
| Q2 24 | 0.37× | -1.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
